Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
This report aims to provide a comprehensive presentation of the global market for Pulmonary Drug Delivery Devices & Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pulmonary Drug Delivery Devices & Systems. This report contains market size and forecasts of Pulmonary Drug Delivery Devices & Systems in global, including the following market information:
Global Pulmonary Drug Delivery Devices & Systems Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Pulmonary Drug Delivery Devices & Systems Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Pulmonary Drug Delivery Devices & Systems companies in 2022 (%)
The global Pulmonary Drug Delivery Devices & Systems market was valued at US$ 2877.4 million in 2022 and is projected to reach US$ 3791.5 million by 2029, at a CAGR of 4.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America dominates the dominant drug delivery devices/systems market position. Major local pharmaceutical and medical device manufacturers, advanced medical infrastructure, population ageing, high disposable income and lifestyle changes are all factors driving the overall growth of the North American pharmaceutical drug delivery devices/systems market.
We surveyed the Pulmonary Drug Delivery Devices & Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pulmonary Drug Delivery Devices & Systems Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices & Systems Market Segment Percentages, by Type, 2022 (%)
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Global Pulmonary Drug Delivery Devices & Systems Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices & Systems Market Segment Percentages, by Application, 2022 (%)
Hospitals and Clinics
Homecare
Global Pulmonary Drug Delivery Devices & Systems Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Pulmonary Drug Delivery Devices & Systems Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pulmonary Drug Delivery Devices & Systems revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Pulmonary Drug Delivery Devices & Systems revenues share in global market, 2022 (%)
Key companies Pulmonary Drug Delivery Devices & Systems sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Pulmonary Drug Delivery Devices & Systems sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pulmonary Drug Delivery Devices & Systems, market overview.
Chapter 2: Global Pulmonary Drug Delivery Devices & Systems market size in revenue and volume.
Chapter 3: Detailed analysis of Pulmonary Drug Delivery Devices & Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pulmonary Drug Delivery Devices & Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pulmonary Drug Delivery Devices & Systems capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pulmonary Drug Delivery Devices & Systems Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pulmonary Drug Delivery Devices & Systems Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pulmonary Drug Delivery Devices & Systems Overall Market Size
2.1 Global Pulmonary Drug Delivery Devices & Systems Market Size: 2022 VS 2030
2.2 Global Pulmonary Drug Delivery Devices & Systems Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Pulmonary Drug Delivery Devices & Systems Sales: 2018-2030
3 Company Landscape
3.1 Top Pulmonary Drug Delivery Devices & Systems Players in Global Market
3.2 Top Global Pulmonary Drug Delivery Devices & Systems Companies Ranked by Revenue
3.3 Global Pulmonary Drug Delivery Devices & Systems Revenue by Companies
3.4 Global Pulmonary Drug Delivery Devices & Systems Sales by Companies
3.5 Global Pulmonary Drug Delivery Devices & Systems Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pulmonary Drug Delivery Devices & Systems Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pulmonary Drug Delivery Devices & Systems Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Players in Global Market
3.8.1 List of Global Tier 1 Pulmonary Drug Delivery Devices & Systems Companies
3.8.2 List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Market Size Markets, 2022 & 2030
4.1.2 Metered Dose Inhalers
4.1.3 Dry Powder Inhalers
4.1.4 Nebulizers
4.1.5 Accessories
4.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
4.2.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2023
4.2.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2024-2030
4.2.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
4.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
4.3.1 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales, 2018-2023
4.3.2 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales, 2024-2030
4.3.3 By Type - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
4.4 By Type - Global Pulmonary Drug Delivery Devices & Systems Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Market Size, 2022 & 2030
5.1.2 Hospitals and Clinics
5.1.3 Homecare
5.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
5.2.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2023
5.2.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2024-2030
5.2.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
5.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
5.3.1 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales, 2018-2023
5.3.2 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales, 2024-2030
5.3.3 By Application - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
5.4 By Application - Global Pulmonary Drug Delivery Devices & Systems Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Market Size, 2022 & 2030
6.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue & Forecasts
6.2.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2023
6.2.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, 2024-2030
6.2.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
6.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales & Forecasts
6.3.1 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales, 2018-2023
6.3.2 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales, 2024-2030
6.3.3 By Region - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030
6.4.2 By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, 2018-2030
6.4.3 US Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.4.4 Canada Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.4.5 Mexico Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030
6.5.2 By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, 2018-2030
6.5.3 Germany Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.4 France Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.5 U.K. Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.6 Italy Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.7 Russia Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.8 Nordic Countries Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.5.9 Benelux Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030
6.6.2 By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, 2018-2030
6.6.3 China Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.6.4 Japan Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.6.5 South Korea Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.6.6 Southeast Asia Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.6.7 India Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030
6.7.2 By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, 2018-2030
6.7.3 Brazil Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.7.4 Argentina Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, 2018-2030
6.8.3 Turkey Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.8.4 Israel Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.8.5 Saudi Arabia Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
6.8.6 UAE Pulmonary Drug Delivery Devices & Systems Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Hovione
7.1.1 Hovione Company Summary
7.1.2 Hovione Business Overview
7.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.1.5 Hovione Key News & Latest Developments
7.2 3M Health Care
7.2.1 3M Health Care Company Summary
7.2.2 3M Health Care Business Overview
7.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.2.5 3M Health Care Key News & Latest Developments
7.3 Bespak
7.3.1 Bespak Company Summary
7.3.2 Bespak Business Overview
7.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.3.5 Bespak Key News & Latest Developments
7.4 BeyonDevices
7.4.1 BeyonDevices Company Summary
7.4.2 BeyonDevices Business Overview
7.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.4.5 BeyonDevices Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 H&T Presspart
7.6.1 H&T Presspart Company Summary
7.6.2 H&T Presspart Business Overview
7.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.6.5 H&T Presspart Key News & Latest Developments
7.7 PARI Respiratory Equipment
7.7.1 PARI Respiratory Equipment Company Summary
7.7.2 PARI Respiratory Equipment Business Overview
7.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.7.5 PARI Respiratory Equipment Key News & Latest Developments
7.8 Philips Respironics
7.8.1 Philips Respironics Company Summary
7.8.2 Philips Respironics Business Overview
7.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.8.5 Philips Respironics Key News & Latest Developments
7.9 SHL
7.9.1 SHL Company Summary
7.9.2 SHL Business Overview
7.9.3 SHL Pulmonary Drug Delivery Devices & Systems Major Product Offerings
7.9.4 SHL Pulmonary Drug Delivery Devices & Systems Sales and Revenue in Global (2018-2023)
7.9.5 SHL Key News & Latest Developments
8 Global Pulmonary Drug Delivery Devices & Systems Production Capacity, Analysis
8.1 Global Pulmonary Drug Delivery Devices & Systems Production Capacity, 2018-2030
8.2 Pulmonary Drug Delivery Devices & Systems Production Capacity of Key Manufacturers in Global Market
8.3 Global Pulmonary Drug Delivery Devices & Systems Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pulmonary Drug Delivery Devices & Systems Supply Chain Analysis
10.1 Pulmonary Drug Delivery Devices & Systems Industry Value Chain
10.2 Pulmonary Drug Delivery Devices & Systems Upstream Market
10.3 Pulmonary Drug Delivery Devices & Systems Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pulmonary Drug Delivery Devices & Systems Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Pulmonary Drug Delivery Devices & Systems in Global Market
Table 2. Top Pulmonary Drug Delivery Devices & Systems Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Pulmonary Drug Delivery Devices & Systems Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Pulmonary Drug Delivery Devices & Systems Revenue Share by Companies, 2018-2023
Table 5. Global Pulmonary Drug Delivery Devices & Systems Sales by Companies, (K Units), 2018-2023
Table 6. Global Pulmonary Drug Delivery Devices & Systems Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Pulmonary Drug Delivery Devices & Systems Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Pulmonary Drug Delivery Devices & Systems Product Type
Table 9. List of Global Tier 1 Pulmonary Drug Delivery Devices & Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pulmonary Drug Delivery Devices & Systems Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2018-2023
Table 15. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2024-2030
Table 16. By Application ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2018-2023
Table 20. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2024-2030
Table 21. By Region ? Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2018-2023
Table 25. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales (K Units), 2024-2030
Table 26. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2018-2023
Table 29. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2024-2030
Table 30. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2018-2023
Table 33. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2024-2030
Table 34. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2018-2023
Table 37. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2024-2030
Table 38. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2018-2023
Table 41. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales, (K Units), 2024-2030
Table 46. Hovione Company Summary
Table 47. Hovione Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 48. Hovione Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Hovione Key News & Latest Developments
Table 50. 3M Health Care Company Summary
Table 51. 3M Health Care Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 52. 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. 3M Health Care Key News & Latest Developments
Table 54. Bespak Company Summary
Table 55. Bespak Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 56. Bespak Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bespak Key News & Latest Developments
Table 58. BeyonDevices Company Summary
Table 59. BeyonDevices Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 60. BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. BeyonDevices Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 64. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. H&T Presspart Company Summary
Table 67. H&T Presspart Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 68. H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. H&T Presspart Key News & Latest Developments
Table 70. PARI Respiratory Equipment Company Summary
Table 71. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 72. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. PARI Respiratory Equipment Key News & Latest Developments
Table 74. Philips Respironics Company Summary
Table 75. Philips Respironics Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 76. Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Philips Respironics Key News & Latest Developments
Table 78. SHL Company Summary
Table 79. SHL Pulmonary Drug Delivery Devices & Systems Product Offerings
Table 80. SHL Pulmonary Drug Delivery Devices & Systems Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. SHL Key News & Latest Developments
Table 82. Pulmonary Drug Delivery Devices & Systems Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 83. Global Pulmonary Drug Delivery Devices & Systems Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Pulmonary Drug Delivery Devices & Systems Production by Region, 2018-2023 (K Units)
Table 85. Global Pulmonary Drug Delivery Devices & Systems Production by Region, 2024-2030 (K Units)
Table 86. Pulmonary Drug Delivery Devices & Systems Market Opportunities & Trends in Global Market
Table 87. Pulmonary Drug Delivery Devices & Systems Market Drivers in Global Market
Table 88. Pulmonary Drug Delivery Devices & Systems Market Restraints in Global Market
Table 89. Pulmonary Drug Delivery Devices & Systems Raw Materials
Table 90. Pulmonary Drug Delivery Devices & Systems Raw Materials Suppliers in Global Market
Table 91. Typical Pulmonary Drug Delivery Devices & Systems Downstream
Table 92. Pulmonary Drug Delivery Devices & Systems Downstream Clients in Global Market
Table 93. Pulmonary Drug Delivery Devices & Systems Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Pulmonary Drug Delivery Devices & Systems Segment by Type in 2022
Figure 2. Pulmonary Drug Delivery Devices & Systems Segment by Application in 2022
Figure 3. Global Pulmonary Drug Delivery Devices & Systems Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pulmonary Drug Delivery Devices & Systems Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Pulmonary Drug Delivery Devices & Systems Revenue, 2018-2030 (US$, Mn)
Figure 7. Pulmonary Drug Delivery Devices & Systems Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Pulmonary Drug Delivery Devices & Systems Revenue in 2022
Figure 9. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 11. By Type - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 12. By Type - Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit), 2018-2030
Figure 13. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 15. By Application - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 16. By Application - Global Pulmonary Drug Delivery Devices & Systems Price (USD/Unit), 2018-2030
Figure 17. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 20. By Region - Global Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 21. By Country - North America Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 22. By Country - North America Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 23. US Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 28. Germany Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 29. France Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 37. China Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 41. India Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 43. By Country - South America Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 44. Brazil Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Market Share, 2018-2030
Figure 48. Turkey Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Pulmonary Drug Delivery Devices & Systems Revenue, (US$, Mn), 2018-2030
Figure 52. Global Pulmonary Drug Delivery Devices & Systems Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Pulmonary Drug Delivery Devices & Systems by Region, 2022 VS 2030
Figure 54. Pulmonary Drug Delivery Devices & Systems Industry Value Chain
Figure 55. Marketing Channels
